Assistant Professor
Cruzeiro do sul University
مجموع سنوات الخبرة :18 years, 7 أشهر
Professor of Organic Chemistry, Analytical Chemistry, Pharmaceutical Technology,
Pharmacology, Toxicology, and Biotechnology.
Assembly of clinical study protocols for equivalence of medical and hospital materials.
Adequacy of toxicological and risk studies to ISOs 10993/13485/14971. Design of clinical
studies for medical materials. Interpretation of toxicological results and preparation of clinical
and technical protocols. Interpretation of the principles of toxicology and human and
environmental health toxicity data and assessment methodology.
Regulatory Affairs
Work in multi-functional teams interfacing with regulatory, Chemical, marketing, and sales
teams developing innovation master plans and commercial go to market strategies. Ensuring
that appropriate, up-to-date records are maintained for compliance.
responsible for stock control and inventory
Monitor product lines, assess performance, and propose actions to rectify problem areas.
Monitor competitors on a regular basis.
Plan and implement preclinical research studies in alternative biological models (3Rs
principle). Implementation of alternative in vitro and in vivo methods and interpretation of
kinetic data. Development of formulations in nanotechnology and physical chemical and
analytical characterization studies (AFM, XRD, TGA, XPS, DLS, UV-Vis, Raman spectroscopy
and NMR). Administer protocol and related study training to assigned sites and establish
Responsible for stock control and inventory in Irish drug stores. Monitor product lines, assess performance and propose actions to rectify problem areas. Monitor competitors on a regular basis.
Investigator in the process of new drugs (IND) for the treatment of hospital infections (multidrug
resistant Staphylococcus aureus, extended spectrum beta-lactamase and fungal infections).
Responsible for designing, synthetic and antimicrobial analysis of new drug development.
Representing the research in national and international symposium of medicinal chemistry and
clinical research.
Organic synthesis of studies aiming to develop new compounds with antifungal activity.
Determination of the minimum inhibitory concentration (MIC), preclinical and cytotoxicity
studies.
Wrote articles and scientific book chapters in the fields of pharmacology and toxicology, which involve organic synthesis studies of new compounds with promising activity against bacterial and fungal infections. Conducts toxicological studies with alternative models prioritizing the 3Rs (Replacement, Reduction and Refinement). Lecturer and university professor, teaching courses and training in related fields.
Designed, managed and analyzed pre-clinical pharmacology, toxicology and ADME studies in house, with academic and corporate collaborators. Collaborated cross-functionally with discovery, translational medicine, regulatory and clinical development team to advance therapeutics through R&D pipeline.
لقد تم حذف الرابط بسبب انتهاكه لسياسة الموقع. يرجى التواصل مع قسم الدعم لمزيد من المعلومات.